Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 15 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 10561670

    Compositions comprising acidic extracts of mastic gum

    REGENERA PHARMA LTD. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  2. US 10564149

    Populations of mesenchymal stem cells that secrete neurotrophic factors

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  3. US 10555963

    Klotho protein and related compounds for the treatment and diagnosis of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  4. US 10548890

    Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same

    Platform Brightworks Two, Ltd. · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  5. US 10543222

    Therapy for inhibition of single-stranded RNA virus replication

    RedHill Biopharma Ltd. · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted
  6. US 10532079

    Extracts and beverages containing 2,5-piperazinedione, 3,6-bis(phenylmethyl)-, (3S,6S)-

    SUNTORY BEVERAGE & FOOD ASIA PTE. LTD. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  7. US 10526373

    Peptide showing melanin generation-promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted
  8. US 10513543

    Antigen chimera, antigen composition, vaccine, method of preparing the same and cassette thereof

    SHANGHAI UNITED CELL BIOTECHNOLOGY CO., LTD. · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted
  9. US 10507225

    Powder for regulating intestinal flora and protecting gastric mucosa, preparation method and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted
  10. US 10508136

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted
  11. US 10508140

    Peptide having hair growth-promoting activity and/or melanin generation-promoting activity, and use thereof

    CAREGEN CO., LTD. · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted
  12. US 10501444

    Inhibitors of influenza virus replication, application methods and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted
  13. US 10494364

    Cathepsin K inhibitors and application thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted
  14. US 10493065

    Formulations and methods of manufacturing formulations for use in colonic evacuation

    RedHill Biopharma Ltd. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted
  15. US 10492518

    Blood lipid-lowering composition, method for preparing the same and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted
  16. US 10487113

    Peptide having activity to improve skin condition and use thereof

    CAREGEN CO., LTD. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  17. US 10479830

    Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

    CHEMOMAB LTD. · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  18. US 10465004

    Frizzled receptor antibodies for treatment of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  19. US 10463654

    Combination therapies for treating cancer

    RedHill Biopharma Ltd. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  20. US 10455849

    Method for the preparation of a protein peptide, a protein peptide and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  21. US 10444237

    Anti-pancreatic cancer monoclonal antibody and use thereof

    NANJING MARKERLINE BIOMEDICAL TECHNOLOGY CO., LTD. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted
  22. US 10434114

    Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics

    RedHill Biopharma Ltd. · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  23. US 10426807

    Bone and joint protection composition and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  24. US 10426810

    Tangerine peel extract and its preparation and application

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted